ACADIA Pharmaceuticals
ACAD
#3637
Rank
โ‚น229.14 B
Marketcap
โ‚น1,374
Share price
-3.01%
Change (1 day)
-10.54%
Change (1 year)

Revenue for ACADIA Pharmaceuticals (ACAD)

Revenue in 2024 (TTM): โ‚น80.56 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น81.63 Billion. an increase over the revenue in the year 2023 that were of โ‚น60.47 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ACADIA Pharmaceuticals from 2003 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น82.16 B35.87%
2023 โ‚น60.47 B41.29%
2022 โ‚น42.80 B18.78%
2021 โ‚น36.03 B11.54%
2020 โ‚น32.30 B33.61%
2019 โ‚น24.17 B54.51%
2018 โ‚น15.64 B96.23%
2017 โ‚น7.97 B577.16%
2016 โ‚น1.17 B28952.68%
2015 โ‚น4.05 M-47.14%
2014 โ‚น7.66 M-89.16%
2013 โ‚น70.73 M-73.67%
2012 โ‚น0.26 B145.71%
2011 โ‚น0.10 B-94.21%
2010 โ‚น1.88 B536%
2009 โ‚น0.29 B288.45%
2008 โ‚น76.42 M-74.22%
2007 โ‚น0.29 B-17.7%
2006 โ‚น0.36 B-26.93%
2005 โ‚น0.49 B147.25%
2004 โ‚น0.19 B-44%
2003 โ‚น0.35 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น16.94 B-79.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.422 T 6,542.95%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.838 T 4,602.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.569 T 9,173.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.116 T 4,942.82%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.51 B-90.79%๐Ÿ‡บ๐Ÿ‡ธ USA